INS Gene Maturity-Onset Diabetes of the Young Type 10 NGS Genetic DNA Test
Comprehensive Genetic Testing for MODY10 Diabetes
The INS Gene Maturity-Onset Diabetes of the Young Type 10 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for diabetes management. This advanced test specifically targets mutations in the insulin gene (INS) that cause MODY10, a rare monogenic form of diabetes that typically manifests in adolescence or early adulthood. Unlike type 1 or type 2 diabetes, MODY10 follows an autosomal dominant inheritance pattern and requires specialized treatment approaches.
What This Test Measures and Detects
Our comprehensive NGS-based genetic test analyzes the entire INS gene sequence to identify pathogenic variants associated with MODY10. The test specifically detects:
- Point mutations in the insulin gene coding regions
- Small insertions and deletions affecting insulin production
- Genetic variants that impair insulin synthesis and secretion
- Mutations leading to abnormal proinsulin processing
- Genetic markers for autosomal dominant diabetes inheritance
Who Should Consider This Test
This genetic test is particularly recommended for individuals who exhibit:
- Diabetes diagnosis before age 25 with strong family history
- Mild fasting hyperglycemia without typical type 2 diabetes features
- Absence of pancreatic autoantibodies
- Family members with multiple generations affected by diabetes
- Inadequate response to standard diabetes medications
- Unexplained neonatal diabetes or hyperglycemia in infancy
Clinical Benefits of INS Gene Testing
Undergoing the INS Gene Maturity-Onset Diabetes of the Young Type 10 test provides numerous clinical advantages:
- Accurate Diagnosis: Differentiates MODY10 from other diabetes types for precise treatment planning
- Personalized Treatment: Enables targeted therapy approaches based on genetic findings
- Family Risk Assessment: Identifies at-risk family members for early intervention
- Improved Outcomes: Prevents diabetes-related complications through early management
- Genetic Counseling: Provides valuable information for family planning decisions
Understanding Your Test Results
Our comprehensive genetic report provides clear interpretation of your results:
- Positive Result: Indicates presence of INS gene mutation confirming MODY10 diagnosis
- Negative Result: Suggests MODY10 is unlikely, guiding investigation toward other diabetes types
- Variant of Uncertain Significance: Requires additional family studies for clarification
- Carrier Status: Identifies individuals who may pass the mutation to offspring
All results are accompanied by detailed clinical interpretation and recommendations from our genetic specialists.
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Control of Your Diabetes Management
Don’t let uncertainty about your diabetes diagnosis affect your treatment outcomes. The INS Gene Maturity-Onset Diabetes of the Young Type 10 NGS Genetic DNA Test provides the clarity needed for effective diabetes management. Our genetic counselors are available to discuss your results and provide personalized recommendations.
Ready to get answers? Book your test today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward personalized diabetes care.
